Synthesis, molecular docking, and in vivo antidiabetic evaluation of new benzylidene-2,4-thiazolidinediones as partial PPAR-γ agonists

Peroxisome proliferator-activated receptor-γ (PPAR-γ) partial agonists or antagonists, also termed as selective PPAR-γ modulators, are more beneficial than full agonists because they can avoid the adverse effects associated with PPAR-γ full agonists, such as weight gain and congestive heart disorder...

Descripción completa

Detalles Bibliográficos
Autores principales: Najmi, Asim, Alam, Md Shamsher, Thangavel, Neelaveni, Taha, Manal M. E., Meraya, Abdulkarim M., Albratty, Mohammed, Alhazmi, Hassan A., Ahsan, Waquar, Haque, Anzarul, Azam, Faizul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645977/
https://www.ncbi.nlm.nih.gov/pubmed/37963936
http://dx.doi.org/10.1038/s41598-023-47157-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645977/
https://www.ncbi.nlm.nih.gov/pubmed/37963936
http://dx.doi.org/10.1038/s41598-023-47157-x

Ejemplares similares